60
AVSF - Alloy Therapeutics 2026, LLC files an open-ended venture capital fund
New fund · Venture capital · Open-ended · BOSTON, MA · Form D filed 2026-07-17
First filing by this entity
Why now — by persona
Relevant to: Fund administrator, Fund audit & tax. Lead card pending.
People on the filing
| Michael Collins | CEO of Alumni Ventures LLC, the Issuers Sole Manager |
Signed by Hilary Ncala, Sr VP, Alumni Funds of Issuers Sole Manager.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.